Eisler Capital (UK)’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$778K Buy
38,281
+17,153
+81% +$351K ﹤0.01% 508
2024
Q2
$477K Buy
+21,128
New +$553K ﹤0.01% 462
2024
Q1
Sell
-100,523
Closed -$2.86M 615
2023
Q4
$3.17M Sell
100,523
-82,715
-45% -$2.24M 0.02% 369
2023
Q3
$5.14M Buy
183,238
+133,525
+269% +$4.58M 0.03% 271
2023
Q2
$1.83M Sell
49,713
-24,099
-33% -$736K 0.01% 276
2023
Q1
$2.21M Buy
+73,812
New +$2.43M 0.02% 229

Other funds holding CC

Eisler Capital (UK)'s CC Position: Q3 2024 in Review

Eisler Capital (UK) increased its Chemours (CC) stake by 81% in Q3 2024, buying an estimated $351K and bringing the position to 38,281 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

Eisler Capital (UK) first reported a position in CC in Q1 2023 and has held it in 6 quarters since. The position peaked at $5.14M in Q3 2023. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Eisler Capital (UK) held 38,281 shares of Chemours worth $778K as of Q3 2024.
  • Eisler Capital (UK) bought 17,153 Chemours shares in Q3 2024, an estimated $351K.
  • Chemours made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #508 holding.
  • Eisler Capital (UK) first reported a position in Chemours in Q1 2023 and has held it in 6 quarters since.
  • Eisler Capital (UK)'s Chemours position peaked at $5.14M in Q3 2023.
  • 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.